Industry

Implementation of the Pharmaceutical Track & Trace Pilot Project

Date: 15 October 2023 - 5:22am

Any questions should be directed to:

Urusetia,
Jawatankuasa Agenda Keselamatan dan Integriti Pengubatan Kebangsaan
Melalui Pengesanan dan Penjejakan Produk Farmaseutikal (Track & Trace)

a/t:

  • En. Mohd Azuwan bin Mohd Zubir
    Phone: 03-7841 3629
  • En. Zainuddin bin Ma'amor
    Phone: 03-7841 3647

Email: pharmacy@moh.gov.my

English

Invitation to Engagement Sessions on Medicines Price Mechanism and Cost Benefit Analysis (CBA)

Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia (KKM) akan mengadakan sesi penerangan secara atas talian berkaitan status terkini Mekanisme Harga Ubat dan kajian Cost Benefit Analysis (CBA) bagi impak pelaksanaannya terhadap pihak berkepentingan.

Jemputan sesi penerangan ini adalah terbuka kepada semua pihak yang berkaitan mengikut 3 kumpulan pihak berkepentingan seperti berikut:

Sesi/Kumpulan

Tarikh

Location/place: 
Online
Date: 
Monday, 4 January 2021 to Wednesday, 6 January 2021

BE CAUTIOUS WHEN BUYING MEDICINES ONLINE

Date: 19 September 2019 - 2:38pm

For further information, kindly visit to https://www.pharmacy.gov.my/v2/en/website/waspada-belian-ubat-online

PN. NORMAWATI BINTI MOHAMED NOOR,

SEKSYEN KAWAL SELIA IKLAN UBAT,

CAWANGAN KAWALAN IKLAN,

BAHAGIAN PENGUATKUASAAN FARMASI, KKM

normawati_mn@moh.gov.my

03-78413239

Aktiviti Penyelenggaraan Sistem Program Perkhidmatan Farmasi

Date: 28 September 2017 - 8:15am

Adalah dimaklumkan, bermula tarikh 29 September 2017 jam 5.00 petang sehingga 2 Oktober 2017 jam 12 tengah hari akan berlaku gangguan terdapat semua sistem di bawah Program Perkhidmatan Farmasi. Ini bagi memberi laluan kepada kerja-kerja penyelenggaraan elektrik untuk peningkatan mutu perkhidmatan Kerajaan sedia ada.

Berikut adalah senarai sistem-sistem yang akan mengalami gangguan capaian sepanjang tempoh tersebut:

Garis Panduan untuk Pemantauan Keselamatan Produk Erythropoietin Stimulating Agents (ESAs) & Pelaporan Kesan Advers Pure Red Cell Aplasia (PRCA)

Date: 14 April 2016 - 2:45pm

Pure Red Cell Aplasia (PRCA) is one of the adverse effects due to usage of Erythropoietin Stimulating Agents (ESAs).  The definition for PRCA is as follows:

‘Epoiten-associated pure red cell aplasia (PRCA) is characterized by severe anemia, low reticulocyte count, erythroblasts absence, epoetin non-response, and neutralizing antibodies against erythropoietin (EPO).  PRCA is a rare adverse effect resulting from antibodies to Erythropoietin Stimulating Agents (ESAs) that cross-react with endogenous erythropoietin.’

English

9th National Pharmacy R&D Conference 2016 (2nd Announcement)

Location/place: 
Kuala Lumpur/Putrajaya
Date: 
Monday, 8 August 2016 to Wednesday, 10 August 2016

National Antimicrobial Guideline (NAG) 2024, 4th Edition

Date: 29 July 2024 - 8:44am

The National Antimicrobial Guideline (NAG) is an important reference to ensure rational use of antimicrobials which in turn will reduce the risk of antimicrobial resistance.

English

Garis Panduan Petugas Haji Malaysia Rombongan Perubatan (Perkhidmatan Farmasi)

Date: 22 September 2025 - 2:28pm

The Garis Panduan Petugas Haji Malaysia Rombongan Perubatan (Perkhidmatan Farmasi) is published as the official reference for all pharmacy personnel involved in Hajj operations.

English

Guideline for the Ministry of Health Malaysia Drug Formulary (FUKKM), Fourth Edition (2025)

Date: 29 July 2025 - 7:47am

This guideline serves as a reference for all healthcare personnel across hospitals, clinics and institutions under the Ministry of Health Malaysia (MOH) regarding the use of the MOH Drug Formulary and matters related to formulary management within MOH facilities.

English

IMPACT OF POOLED PROCUREMENT ON MEDICINES PRICING IN THE PUBLIC SECTOR 2024

Date: 26 June 2025 - 8:34am

This report presents a retrospective study the impact of pooled procurement on medicines pricing involving the Ministry of Health (MOH), Ministry of Defence (MOD), and Ministry of Higher Education (MOHE). The study covering 82 medicines based on two year contract signed before (2018-2020) and after (2020-2022) after the implementation of pooled procurement.

English

Pages